C. Nougier, R. Benoit, M. Simon, H. Desmurs-clavel, G. Marcotte et al.,

, Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis, J Thromb Haemost, 2020.

M. J. Hollestelle, F. Van-der-meer, and P. Meijer, Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data, Clin Chem Lab Med, 2020.

M. Hardy, T. Lecompte, J. Douxfils, S. Lessire, J. M. Dogne et al., Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory, Thromb J
URL : https://hal.archives-ouvertes.fr/hal-02956178

, Online ahead of print

J. Douxfils, L. Morimont, C. Bouvy, M. De-saint-hubert, B. Devalet et al., Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application, J Thromb Haemost, vol.17, pp.1273-87, 2019.

M. Ranucci and E. Baryshnikova, Sensitivity of Viscoelastic Tests to Platelet Function, J Clin Med, vol.9, 2020.

D. C. Rijken, E. Hoegee-de-nobel, A. F. Jie, D. E. Atsma, M. J. Schalij et al.,

, Development of a new test for the global fibrinolytic capacity in whole blood, J Thromb Haemost, vol.6, pp.151-158, 2008.

G. J. Kuiper, M. C. Kleinegris, R. Van-oerle, H. M. Spronk, M. D. Lance et al.,

, Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity

, Thromb J, vol.14, p.1, 2016.

C. B. Keragala, R. L. Medcalf, and P. S. Myles, Fibrinolysis and COVID-19: a tale of two sites?, J Thromb Haemost, 2020.

K. Suzuki, H. Wada, H. Imai, T. Iba, J. Thachil et al., A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH, J Thromb Haemost, vol.16, pp.1442-1446, 2018.

S. E. Rodgers, A. Wong, R. D. Gopal, B. J. Dale, E. M. Duncan et al., Evaluation of preanalytical variables in a commercial thrombin generation assay, Thromb Res, vol.134, pp.160-164, 2014.